Aclarubicin

Also known as: Aclacinomycin A

Therapeutic indications

Aclarubicin is indicated for:

Acute leukemias

at least one of
Acute lymphoblastic leukaemia

Acute myeloid leukaemia

Acute promyelocytic leukaemia

Acute monocytic leukaemia

Acute megakaryoblastic leukaemia

Acute leukaemia of unspecified cell type

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Intravenous

Contraindications

Aclarubicin is contraindicated in the following cases:

Pre-existing heart disorder

at least one of
Chronic rheumatic heart diseases

Ischaemic heart diseases

Other forms of heart disease

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner